Chemence Medical Inc. recently announced it received Food and Drug Administration clearance to market and sell Exofin Fusion®, a new skin closure system for medium to large wounds. The new skin closure system reportedly combines a self-adhering flexible mesh strip, mesh anchors and a fast-curing 2-octyl cyanoacrylate topical adhesive to quickly close and seal large incisions while forming an immediate microbial barrier to protect against infections.
“Our new skin closure system can really improve the operating room experience for doctors and patients when closing larger wounds,” said Jeff Roberson, president of Chemence Medical. “The self-adhering mesh and anchor system allows for easy application and enables surgeons to close incisions faster than sutures, while the adhesive cures in less than a minute. Meanwhile, the waterproof microbial barrier reduces the patient’s likelihood of readmission due to infection, allows them to shower immediately after surgery, and the innovative anchor system improves comfort during removal.”
For more information, visit www.chemencemedical.com.
Report Abusive Comment